Category Archives: Mergers and Acquisitions

Will innovation pay the price for med-tech biggering?

The urge to go on biggering and biggering and biggering has taken over the med-tech world. Barely a year after Zimmer and Biomet completed a $14 billion merger to become the second largest orthopedic device maker, the company now plans…

FacebookTwitterGoogle+Share

Boston Scientific flies the W flag

It took 10 years but Boston Scientific (BSX) may have finally overcome its ill-advised 2006 Guidant acquisition. The company’s shares hit a decade high Wednesday, at one point spiking nearly 12 percent to $22.05 after knocking its first quarter sales…

FacebookTwitterGoogle+Share

We wish you a … tax repeal!

Right about this time last week, somewhere between the third slice of pumpkin pie and a turkey-induced coma, my mind drifted over some of the stories Medical Device Daily has covered in 2014 and all the things the med-tech industry…

FacebookTwitterGoogle+Share

Corporate greed vs. the American Dream

In 2004 my hometown lost its largest employer to corporate greed. I was a young reporter for the local newspaper, The Register-Mail, when Maytag closed its doors in 2004, forcing roughly 1,600 workers in Galesburg, Illinois and surrounding towns out…

FacebookTwitterGoogle+Share

Stryker S&N acquisition rumors bolster recent orthopedic space consolidation

While orthopedic implant maker Stryker (Kalamazoo, Michigan) said today that  it did not intend to make an offer for Smith & Nephew (S&N; London) after a report in the Financial Times forced its hand, it seems likely that such a…

FacebookTwitterGoogle+Share

Enough stinky greens, med-tech wants dessert!

Change is what the American public was promised (or some might say threatened with) during the 2008 presidential election and for better or worse, the healthcare industry worldwide has been served an extra large helping of that change over the…

FacebookTwitterGoogle+Share

A refreshing take on the state of the med-tech industry

Here at Medical Device Daily we’ve become accustomed to the doom-and-gloom stories about our industry. The medical device tax provision in the Affordable Care Act and other emerging realities of healthcare reform along with worldwide economic sluggishness, regulatory and reimbursement challenges, consolidation…

FacebookTwitterGoogle+Share

Oops! … Roche did it again

It’s doubtful that Britney Spears’ 12-year-old hit single, Oops! . . . I did it again, entered into Roche’s mind when the firm disclosed a hostile takeover bid to acquire Illumina late last month for $44.50 a share in cash,…

FacebookTwitterGoogle+Share

Flashback: Three med-tech stories from August 2009

Those in the business of therapeutic or diagnostic devices know how quickly things can change, so let’s take a quick look at a few stories that appeared in Medical Device Daily in August 2009. After all, two years are less…

FacebookTwitterGoogle+Share

Picking your poison: Wall Street or Venture Capital?

Life is full of choices, not all of them pleasant. For device makers of late, this definitely holds true. Firms in the venture capital end of things are not necessarily worried that VC has utterly abandoned med-tech, but it would…

FacebookTwitterGoogle+Share

Marketo